Rahul Arora positive on FMCG & pharma space

Rahul Arora - CEO at Nirmal Bang Institutional Equities told CNBC-TV18, "For Bata India, the last quarter results were bad but the stock did not fall. So people are sort of buying the growth story on FMCG and pharma. We have been historically positive on both and we continue to be positive."

"However, Natco Pharma with the run it had off late at Rs 2,000 plus, in the immediate short-term I do not think you will get too much but I retain my bullish stance over longer period of time," he said.